Kastalia Medrano

    Kastalia is Filter‘s deputy editor. She previously worked at a number of other media outlets and wouldn’t recommend the drug coverage at any of them. When not at Filter, she works with drug users in NYC and drug checkers in North Carolina to track hyperlocal supply changes, and cohosts a national stimulant users call with Isaac Jackson. She uses meth daily and other drugs sometimes.

    FDA Inches Closer to OTC Narcan—at the Expense of Generic Naloxone

    Advisors to the Food and Drug Administration have voted unanimously in support of making ...

    SOTU: Biden Promises Fentanyl Crackdowns, OUD Meds in Prisons

    On February 7, President Joe Biden delivered the State of the Union address before ...

    DOJ Delays Safehouse Response to 2023, an Unexpected Blow

    The Department of Justice was expected to filed its long-awaited response to the ongoing ...

    Four States Close Prison Slavery Loopholes; Louisiana Votes Against

    Alabama, Oregon, Tennessee and Vermont have closed loopholes in their state constitutions that had ...

    FDA Exempts Harm Reduction From Biggest Naloxone Access Restrictions

    On September 22, the Food and Drug Administration announced that harm reduction naloxone suppliers ...

    “Rainbow Fentanyl” Is Probably a Good Thing, at This Point

    When Toronto’s Moss Park Overdose Prevention Site opened as an unsanctioned service in August ...

    The Pfizer Naloxone Shortage Ends, Leaving Us With Just the Regular One

    [Read Filter‘s August 1 story introducing Remedy Alliance’s naloxone distribution here.]   In the ...

    Exclusive: For the First Time, Harm Reduction Gets a Naloxone of Its Own

    In late April 2021, a manufacturing disruption brought Pfizer’s naloxone production to a standstill, ...